The seal-inspection tool forms part of the PowerChek and PowerChek Plus x-ray inspection systems. These multi-tasking inspection tools are the technological defenders of brand values. They catch several
Ampyra has demonstrated efficacy in people with all four major types of MS (relapsing remitting, secondary progressive, progressive relapsing and primary progressive). Ampyra can be used alone or
Ofatumumab is a human monoclonal antibody with a mode of action. It targets a part of CD20 molecule encompassing an epitope in the small loop (Teeling et al
The international, Phase 3 trial compared sunitinib with placebo in patients with progressive, well-differentiated, malignant pancreatic neuroendocrine tumors. In the study the patients were randomised to either the
The analysis indicates that patients with KRAS wild-type tumors bearing a BRAF mutation also benefit from Erbitux treatment; therefore, KRAS remains the only validated, clinically predictive marker of
The BVA-100 enables measurement of whole blood volume, including plasma volume and red blood cell volume. It also permits measurement of the rate of transudation of albumin across
The company claims that Stemcelex naturally stimulates the population of stem cells within the hair follicle. Over 30 years in development, the product is safe and has shown
The company said that the facility supports several recently announced partnerships, including one with Roche and Genentech, a wholly-owned member of the Roche Group, to develop and commercialise
ACTB1003 is a novel oral kinase inhibitor that targets cancer cells through multiple modes of action. ACTB1003 inhibits cancer cell growth by targeting the FGF receptor family, which
NicOx is seeking approval for an indication for the relief of the signs and symptoms of primary osteoarthritis. This follows the acceptance for filing of a New Drug
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.